Sponsor pipeline

Assistance Publique - Hôpitaux de Paris clinical trial pipeline

Get alerts when Assistance Publique - Hôpitaux de Paris's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

35 trials changed in the last 30 days: 1 stopped, 11 with notable changes, 23 with minor changes only.

  1. Stopped

    BETTANY · Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, · Benign Prostatic Hyperplasia-related Obstruction

    Trial terminated

    Also in this update: Final enrollment: 8 participants (planned 22); Primary completion date changed from estimate of Apr 2025 to Jul 15, 2025

    Assistance Publique - Hôpitaux de ParisPhase 2 NCT06212453 Registry history of NCT06212453 on ClinicalTrials.gov (opens the registry)

  2. Notable

    PROCEDE · Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Early Treatment Using an Automated Delivery System · Type 1 Diabetes

    Primary and study completion pushed from Mar 20, 2028 to Mar 20, 2030

    Also in this update: Enrollment reduced: 60 → 50 participants; Trial arms changed: 3 → 2

    Assistance Publique - Hôpitaux de ParisNot applicable NCT06461065 Registry history of NCT06461065 on ClinicalTrials.gov (opens the registry)

Show 23 trials with minor changes only
  1. Minor

    EVAH · Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection · Primary Immunodeficiency and Secondary Humoral Deficiency

    Trial completed

    Also in this update: Final enrollment: 200 participants (planned 120); Primary completion date changed from estimate of Oct 10, 2026 to Sep 3, 2026

    Assistance Publique - Hôpitaux de ParisNot specified NCT06659588 Registry history of NCT06659588 on ClinicalTrials.gov (opens the registry)

  2. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  3. Minor
    11 trials marked Unknown by the registry's verification sweep
    1. Minor

      PEMCLOCK · Association of Pembrolizumab Infusion Time and Efficacy · Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

      Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Not Yet Recruiting

      Assistance Publique - Hôpitaux de ParisNot specified NCT06418139 Registry history of NCT06418139 on ClinicalTrials.gov (opens the registry)

      Changed

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-19 NCT07880769 Preclinical Type 1 Diabetes: the VIP-1 Study Phase 2/3 Not Yet Recruiting
2026-10-19 NCT07880782 Clinical and MRI Characteristics of Delayed Onset Muscle Soreness (DOMS) of the Shoulder… Not Yet Recruiting
2026-10-19 NCT07881055 Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors Not Yet Recruiting
2026-10-15 NCT07875153 Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic… Phase 3 Not Yet Recruiting
2026-10-08 NCT07865533 Immune Responses and Pulmonary Complications After Cardiac Surgery With Cardiopulmonary… Not Yet Recruiting
2026-10-07 NCT07863414 Description of Clinicians' Predictive Abilities Before and After a Diffusion Tensor… Not Yet Recruiting
2026-10-05 NCT07857252 Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH… Phase 2 Not Yet Recruiting
2026-10-01 NCT07851844 Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory… Not Yet Recruiting
2026-09-29 NCT07846852 Impact of Dietary Intervention Within an Interprofessional Cooperative Protocol for… Not Yet Recruiting
2026-09-25 NCT07842523 Obinutuzumab in Systemic Sclerosis Phase 2 Not Yet Recruiting

Active trials by phase

Early Phase 1
1
Phase 1
4
Phase 1/2
14
Phase 2
68
Phase 2/3
8
Phase 3
111
Phase 4
15
Not charted: 723 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 76

Get alerts when Assistance Publique - Hôpitaux de Paris's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free